TGA Approval

mRESVIA respiratory syncytial virus F protein mRNA (nucleoside modified), 50 micrograms in 0.5 mL, suspension for injection, prefilled syringe. (411450)

ARTG ID

411450

ARTG Name

mRESVIA respiratory syncytial virus F protein mRNA (nucleoside modified), 50 micrograms in 0.5 mL, suspension for injection, prefilled syringe.

Sponsor

Moderna Australia Pty Ltd

ARTG Date

March 28, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Moderna Australia Pty Ltd

Sponsor Item Name

MODERNA AUSTRALIA PTY LTD

Active Ingredients

Ingredient Name

respiratory syncytial virus F protein mRNA (nucleoside modified)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

mRESVIA respiratory syncytial virus F protein mRNA (nucleoside modified), 50 micrograms in 0.5 mL, suspension for injection, prefilled syringe. (411450) - TGA 批准文号 | MedPath

AI-Powered Research